JP2022546861A5 - - Google Patents
Info
- Publication number
- JP2022546861A5 JP2022546861A5 JP2022515704A JP2022515704A JP2022546861A5 JP 2022546861 A5 JP2022546861 A5 JP 2022546861A5 JP 2022515704 A JP2022515704 A JP 2022515704A JP 2022515704 A JP2022515704 A JP 2022515704A JP 2022546861 A5 JP2022546861 A5 JP 2022546861A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- pyridine
- crystal
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025061710A JP2025102940A (ja) | 2019-09-10 | 2025-04-03 | マルチチロシンキナーゼ阻害剤の結晶形、調製方法およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962898469P | 2019-09-10 | 2019-09-10 | |
| US62/898,469 | 2019-09-10 | ||
| PCT/US2020/049986 WO2021050580A1 (en) | 2019-09-10 | 2020-09-09 | Crystalline form of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061710A Division JP2025102940A (ja) | 2019-09-10 | 2025-04-03 | マルチチロシンキナーゼ阻害剤の結晶形、調製方法およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546861A JP2022546861A (ja) | 2022-11-09 |
| JP2022546861A5 true JP2022546861A5 (https=) | 2023-06-16 |
Family
ID=74866002
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515704A Pending JP2022546861A (ja) | 2019-09-10 | 2020-09-09 | マルチチロシンキナーゼ阻害剤の結晶形、調製方法およびその使用 |
| JP2025061710A Pending JP2025102940A (ja) | 2019-09-10 | 2025-04-03 | マルチチロシンキナーゼ阻害剤の結晶形、調製方法およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061710A Pending JP2025102940A (ja) | 2019-09-10 | 2025-04-03 | マルチチロシンキナーゼ阻害剤の結晶形、調製方法およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12466838B2 (https=) |
| EP (1) | EP4027999B1 (https=) |
| JP (2) | JP2022546861A (https=) |
| CN (1) | CN114401720A (https=) |
| CA (1) | CA3150267A1 (https=) |
| WO (1) | WO2021050580A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202302597A (zh) * | 2021-03-10 | 2023-01-16 | 美商米拉蒂醫療公司 | 多重酪胺酸激酶抑制劑之結晶鹽、其製備方法及用途 |
| WO2022240802A1 (en) | 2021-05-10 | 2022-11-17 | Teva Pharmaceuticals International Gmbh | Solid state forms of sitravatinib salts and processes for preparation thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103951583B (zh) * | 2006-12-06 | 2016-01-06 | 科内图斯医药公司 | 一种抑制剂的结晶形式 |
| PL2183254T3 (pl) * | 2007-08-29 | 2017-10-31 | Methylgene Inc | Inhibitory aktywności białkowej kinazy tyrozynowej |
| ES2593279T3 (es) | 2007-08-29 | 2016-12-07 | Methylgene Inc. | Procesos e intermedios para preparar inhibidores de cinasa heterocíclicos condensados |
| US20180237378A1 (en) * | 2015-08-19 | 2018-08-23 | Sandoz Ag | Asymmetric Bisamidation of Malonic Ester Derivatives |
| JP7060694B2 (ja) * | 2018-01-18 | 2022-04-26 | アレイ バイオファーマ インコーポレイテッド | Ｒｅｔキナーゼ阻害剤としての置換ピロロ［２，３－ｄ］ピリミジン化合物 |
| CN109384799B (zh) * | 2018-11-12 | 2020-07-14 | 深圳海王医药科技研究院有限公司 | 一种多靶点激酶抑制剂化合物的晶型a及制备方法和含有其的药物组合物 |
-
2020
- 2020-09-09 JP JP2022515704A patent/JP2022546861A/ja active Pending
- 2020-09-09 EP EP20862121.9A patent/EP4027999B1/en active Active
- 2020-09-09 CA CA3150267A patent/CA3150267A1/en active Pending
- 2020-09-09 US US17/762,713 patent/US12466838B2/en active Active
- 2020-09-09 CN CN202080063504.1A patent/CN114401720A/zh active Pending
- 2020-09-09 WO PCT/US2020/049986 patent/WO2021050580A1/en not_active Ceased
-
2025
- 2025-04-03 JP JP2025061710A patent/JP2025102940A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI736570B (zh) | Ｅｇｆｒ抑制劑游離鹼或其酸式鹽的多晶型、其製備方法和應用 | |
| JP2025102940A5 (https=) | ||
| TWI558702B (zh) | 醫藥活性物質的固態形式 | |
| TWI669304B (zh) | Ｃ－Ｍｅｔ抑制劑結晶型游離鹼或其結晶型酸式鹽及其製備方法和應用 | |
| JP2020517611A5 (https=) | ||
| CN114761001A (zh) | 氮杂环丁烷lpa1受体拮抗剂与抗纤维化药剂的组合 | |
| CN114209699A (zh) | C-met调节剂药物组合物 | |
| WO2005058886A1 (en) | Novel oxazolidinone derivatives | |
| JP2024534014A5 (https=) | ||
| JP7314319B2 (ja) | Ｃｄｋ９阻害剤の結晶多形体及びその製造方法と用途 | |
| JP2022546861A5 (https=) | ||
| JP2023025000A (ja) | （ｓ）－［３，４－ジフルオロ－２－（２－フルオロ－４－ヨードフェニルアミノ）フェニル］［３－ヒドロキシ－３－（ピペリジン－２－イル）アゼチジン－１－イル］－メタノンの結晶性フマル酸塩 | |
| JP2019516749A5 (https=) | ||
| US20060094728A1 (en) | Combination of a SRC kinase inhibitor and a BCR-ABL inhibitor for the treatment of proliferative diseases | |
| JP2024514090A5 (https=) | ||
| AU2022288945A1 (en) | Heteroaryl compounds as inhibitors of tyk2, composition and application thereof | |
| CN104230912B (zh) | 喹啉衍生物、其制备方法及其用途 | |
| JP2024530315A5 (https=) | ||
| JP2020536944A5 (https=) | ||
| WO2006106721A1 (ja) | チロシンキナーゼ阻害作用を有するピリミジン誘導体 | |
| KR20150054860A (ko) | 포스파티딜이노시톨 3-키나아제 억제제의 정제 제형 | |
| IL305788A (en) | A crystalline salt of a multityrosine kinase inhibitor, a method for its preparation and its use | |
| WO2019238102A1 (zh) | 吡啶胺基嘧啶衍生物的晶型及其制备方法 | |
| WO2023134769A1 (zh) | 4'-取代核苷的晶体、其制备方法、组合物和用途 | |
| JP2016505036A5 (https=) |